Silence Therapeutics (SLN) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to -$21.0 million.
- Silence Therapeutics' Profit After Tax rose 4103.65% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.5 million, marking a year-over-year increase of 1528.64%. This contributed to the annual value of -$45.3 million for FY2024, which is 1644.72% up from last year.
- Per Silence Therapeutics' latest filing, its Profit After Tax stood at -$21.0 million for Q3 2025, which was up 4103.65% from -$27.4 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Profit After Tax registered a high of $12.3 million during Q4 2024, and its lowest value of -$35.5 million during Q3 2024.
- For the 5-year period, Silence Therapeutics' Profit After Tax averaged around -$16.1 million, with its median value being -$16.6 million (2021).
- In the last 5 years, Silence Therapeutics' Profit After Tax soared by 16622.85% in 2024 and then tumbled by 113399.65% in 2025.
- Quarter analysis of 5 years shows Silence Therapeutics' Profit After Tax stood at -$15.1 million in 2021, then dropped by 16.64% to -$17.7 million in 2022, then decreased by 5.23% to -$18.6 million in 2023, then surged by 166.23% to $12.3 million in 2024, then tumbled by 270.36% to -$21.0 million in 2025.
- Its Profit After Tax was -$21.0 million in Q3 2025, compared to -$27.4 million in Q2 2025 and -$28.5 million in Q1 2025.